Skip to content

Author

Qifu Li

We have 3 of 360 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Gut microbiome dysbiosis is associated with aldosterone overproduction in idiopathic hyperaldosteronism

Summary Idiopathic hyperaldosteronism (IHA) is a significant cause of secondary hypertension. Emerging evidence links the gut microbiota to endocrine and cardiovascular diseases. We integrated human genetics, multi-omics, and fecal microbiota transplantation (FMT) to investigate the association between IHA and gut micr...

Yuanliang Jiang, Qing-Liang Zeng, Lin-Qiang Ma et al. · 0 citations
Open access Sep 2026

Long‐Term Mortality in Diabetic Foot Disease is Higher Than That of Overall Cancer: Results From Three International Cohorts

Guidelines suggest that the risk of mortality in diabetic foot disease (DFD) is comparable to that of cancer; however, high‐quality evidence is lacking. We aimed to compare the mortality of DFD with that of various cancers based on data from international cohorts.

Qing-Liang Zeng, Zi-Wei Tang, Xiang-Jun Chen et al. · 0 citations
Jul 2026

Proteomic profiling reveals novel insights into hypercortisolism adrenal adenomas.

Comprehensive proteomic profiling of adrenal cortisol-producing adenomas reveals a central role for cholesterol metabolic reprogramming in the pathogenesis of CPAs and downregulation of calcium binding protein 39 like (CAB39L) is uncovered as a key driver of pathological cortisol production.

Xuyang Shi, Yi Yang, Chunxue He et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.